comparemela.com
  1. Home
  2. Live Updates
  3. Peking University Cancer Hospital - Breaking News

Latest Breaking News On - Peking university cancer hospital - Page 9 : comparemela.com

Corvus Pharmaceuticals to Present New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition

Corvus Pharmaceuticals to Present New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLeiv leaSheryl seapyCorvus pharmaceuticals incAmerican society of hematologyUniversity cancer hospital instituteCorvus pharmaceuticalsPresent new interim soquelitinib dataAmerican societyAnnual meetingRefractoryt cellNing dingPeking university cancer hospital

Corvus Pharmaceuticals to Present New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition

Corvus Pharmaceuticals to Present New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSheryl seapyLeiv leaCorvus pharmaceuticals incUniversity cancer hospital instituteGlobenewswire incAmerican society of hematologyCorvus pharmaceuticalsAmerican societyAnnual meetingRefractoryt cellNing dingPeking university cancer hospital

LianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023

LianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Jiajia yuanHong kongKatherine smithBio pharmaYizhe wangElizabeth andersonJosh xuVp communicationsChina national medical products administrationExchange commissionUniversity cancer hospitalEuropean society for medical oncologyBio announces presentationGastric cancerPeking university cancer hospitalMedical oncology

Toripalimab Plus Axitinib May Be New Standard First-Line Treatment for Advanced RCC

Toripalimab plus axitinib can improve PFS, when compared to sunitinib, in treatment-naïve, advanced RCC, a phase 3 trial suggests.

Xinan shengUniversity cancer hospitalShanghai junshi biosciences coPeking university cancer hospitalShanghai junshi biosciences

Toripalimab Plus Axitinib May Be New Standard First-Line Treatment for Advanced RCC

Toripalimab plus axitinib can improve PFS, when compared to sunitinib, in treatment-naïve, advanced RCC, a phase 3 trial suggests.

Xinan shengShanghai junshi biosciences coUniversity cancer hospitalPeking university cancer hospitalShanghai junshi biosciences

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.